|
HS Code |
533188 |
| Chemical Name | 2-Chloro-4-Ethoxyphenylboronic Acid |
| Cas Number | 864070-07-9 |
| Molecular Formula | C8H10BClO3 |
| Molecular Weight | 200.43 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 128-132°C |
| Purity | Typically ≥97% |
| Smiles | B(C1=C(C=CC(=C1)OCC)Cl)(O)O |
| Storage Conditions | Store at 2-8°C, keep tightly sealed |
| Solubility | Soluble in DMSO, methanol, slightly soluble in water |
As an accredited 2-Chloro-4-Ethoxyphenylboronic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 5g package features an amber glass bottle with a tamper-evident cap, labeled as 2-Chloro-4-Ethoxyphenylboronic Acid. |
| Shipping | 2-Chloro-4-Ethoxyphenylboronic Acid is securely packaged in sealed containers to prevent contamination and moisture exposure. Shipments adhere to chemical safety regulations, including proper labeling and documentation. Transport is typically via ground or air freight, depending on destination, with all necessary precautions for storage and handling during transit as per regulatory guidelines. |
| Storage | 2-Chloro-4-Ethoxyphenylboronic Acid should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and sources of ignition. Keep the container tightly closed and protected from moisture, as boronic acids can be sensitive to hydrolysis. Store separate from strong oxidizers and acids. Use appropriate personal protective equipment when handling the chemical. |
Applications of 2-Chloro-4-Ethoxyphenylboronic Acid in Industrial Manufacturing2-Chloro-4-Ethoxyphenylboronic Acid serves as a strategic intermediate in specialty organic synthesis, enabling diverse production routes in the pharmaceutical, agrochemical, and advanced materials sectors. Our manufacturing expertise supports downstream users with consistent product quality and technical guidance for high-value applications. 1. Pharmaceutical Intermediate Synthesis for API ManufacturingLeading pharmaceutical companies utilize this boronic acid in Suzuki-Miyaura coupling to construct biaryl motifs critical for active pharmaceutical ingredient (API) cores, especially in oncology and metabolic disorder therapeutics. This intermediate allows precise incorporation of chloro and ethoxy functionality at early synthetic stages, supporting both small-molecule and targeted therapy project pipelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Synthesis: Herbicide & Fungicide Precursor ProductionProducers of high-value agrochemicals employ this compound to introduce electron-rich aromatic groups via Suzuki coupling, optimizing molecular properties of next-generation herbicides, fungicides, and crop protection intermediates. The chloro-ethoxy substitution fine-tunes the absorption, mobility, and degradation profile of final agroactive compounds. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Functional Materials Development: OLED Intermediate ProductionManufacturers of organic light-emitting diode (OLED) materials integrate this boronic acid in the synthesis of functionalized biphenyl monomers, which are further transformed into hole-transport, electron-transport, or emissive layer components. Accurate placement of chloro- and alkoxy substituents extends conjugation and modifies charge mobility properties in finished optoelectronic polymers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Synthesis: Specialty Aroma and Fragrance IntermediatesProducers of specialty aroma compounds and custom fragrances leverage this boronic acid to construct advanced aromatic ethers and substituted biaryl motifs, imparting unique scent profiles and improved stability in finished perfumery and flavor products. The raw material enters high-purity coupling reactions favoring structurally precise intermediates used in fine chemicals blending. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-Chloro-4-Ethoxyphenylboronic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
We’ve spent years in the boronic acid field, producing and refining specialty molecules used across industries. Among our range, 2-Chloro-4-Ethoxyphenylboronic Acid stands out. The model number most commonly referred to is the CAS number 1042069-81-1, but we see customers in the pharmaceutical and materials fields ask for it by its descriptive name more than anything else. In the plant, our chemists recognize this compound by its distinct combination of a chloro group at the two-position, an ethoxy at the four-position, and the boronic acid moiety. It’s not just the structure; it's how these nodes influence reactivity that matters every day on the shop floor.
On the production line, our technicians have experienced the stability differences firsthand. Many boronic acids, especially those with bulkier or electron-rich groups, present challenges in moisture control and shelf-life. By contrast, 2-Chloro-4-Ethoxyphenylboronic Acid brings manageable handling while still giving chemists that fine control in Suzuki couplings and other cross-coupling reactions. Several project teams in pharmaceuticals turn to this compound for its balance between reactivity and selective compatibility—unlike simpler phenylboronic acids, the chloro and ethoxy substituents shift its electron density in a way that modulates palladium-catalyzed bond formation. We have seen this firsthand where researchers switching from unsubstituted phenylboronic acid to this variant have reported improved yields or reactivity under milder conditions.
The demand for reliability is persistent in our field. Chemical manufacturing doesn’t just rest on purity numbers printed on a sheet; behind every batch, our QA team tracks not just the percentage GC purity (which usually hits well above 98%) but the water content, trace metal residues, free acid, and variations in physical appearance. Our plant uses controlled humidity rooms for storage because we have seen boronic acids lose integrity when warehouse environments swing too much from dry to damp. This doesn't just degrade a product—it disrupts research timelines and drives up costs for both manufacturer and end user. That’s why on our floor, process control involves more than visual inspections. We run repeated Karl Fischer titrations, and the requirement isn't just a spec—it’s a practice based on repeated conversations with customers troubleshooting low yield reactions. The most successful projects are built from acknowledging these ground-level issues.
Some users ask how 2-Chloro-4-Ethoxyphenylboronic Acid compares with other phenylboronic acids. We have direct experience running production lots of many analogs: 2-Chlorophenylboronic acid, 4-Ethoxyphenylboronic acid, 2,4-Dichlorophenylboronic acid, and the plain phenylboronic acid itself. Many overlook the impact small substituent changes have on solubility and reactivity, but our technical support team sees project outcomes shift with such modifications. The presence of both the chloro and ethoxy groups adjusts the compound’s solubility profile. Some analogs dissolve poorly in standard solvents used for cross-coupling, causing issues for scale-up. The ethoxy group injects more organic character to the molecule, increasing compatibility with organic solvents, while the chloro group tweaks reactivity and steers subsequent ring substitutions during downstream modifications.
Compared to monosubstituted analogs, this compound resists hydrolysis better in storage, though it should go without saying boronic acids in general require dry conditions. We package this product in tight-sealed containers with desiccants, and staffers have developed an eye for signs of caking or discoloration that can indicate quality drift before drummed-out batches go to the warehouse. We have discontinued product lines in the past when stability or purity slipped below client standards—our credibility in the field has come from holding customers’ lab goals above short-term production runs.
Cross-coupling reactions like Suzuki-Miyaura are widely referenced, but the laboratory reality often runs into roadblocks on scale, yield, and reproducibility. Over the years, we’ve watched the substitution pattern of the aryl ring drive these challenges. End users in pharmaceutical companies select 2-Chloro-4-Ethoxyphenylboronic Acid because its substitution profile assists in coupling to heterocyclic partners used in kinase inhibitor scaffolds, antibiotics, and material science polymers. There’s a tangible difference between what looks promising in a catalog and what consistently generates high yields in kilo-lot production. In several cases, process chemists have relayed that switching to our material—after running into trouble sourcing consistent lots elsewhere—has let them avoid months of route scouting and debugging. We don’t just supply a chemical—we listen when users report on side reactions, isomerization, or trace impurity artifacts.
At the manufacturing level, our team sees every aspect of the process—from raw material sourcing to waste management. The synthesis involves organometallic intermediates, which means handling steps can’t just follow textbook conditions. The temperature control has proven critical in ensuring low impurity levels, and we adopted incremental changes to the reaction quench and crystallization steps over several years. The feedback loop from customer labs back to our process development bench provides more than anecdotal data. For example, early batches occasionally arrived with minute contamination from processing solvents, flagged in high-resolution LC-MS by several pharmaceutical clients. In response, we implemented new filtration and solvent exchange routines, reducing these artifacts below detection limits. This didn't just solve one client’s issue; it improved every downstream application. Regular conversations with procurement and R&D teams on the user end highlight nuances in color, particle size, or even smell that impact real-world lab workflow. We respond with process changes because performance in the field reveals truths missed by controlled pilot runs. If a batch clumps or cakes, we retrace storage and packaging decisions to catch what went off-course.
Our clients—especially in process research—often design new aryl building blocks. They are sensitive to price, performance, and documentation. They share details about reactions succeeding only with certain lots, or about needing pre-dried solvents to unlock reactivity. We encourage this feedback, as it helps us refine both our internal screening and the guidance we share with future customers. Over the years, we noticed that academic users want detailed analytical data, while pharma groups ask about scale-up, regulatory risks, and reproducibility. A robust COA, spanning NMR, HPLC, water content, and even origin statements for raw materials, grew out of these cumulative requests. Every insight from downstream users has ended up reshaping batch qualifications, influencing purity thresholds, and pushing us toward ever tighter in-process controls.
Operators in large-scale synthesis discuss issues that rarely appear in academic papers. One frequent point: the hygroscopic nature of boronic acids. If moisture sneaks into the supply chain or sits in opened bottles, the reactivity drops in carbon–carbon bond forming reactions. Failures often land on the lap of the manufacturer for troubleshooting. Our floor staff can trace root causes by batch records, and we've invested in packaging lines designed to seal and label in humidity-controlled environments. Once, a regular client called after observing a yield drop. Reviewing our production logs, we traced the problem to a summer heat spike and a change in warehouse air conditioning. Such transparency built trust—something that’s impossible to reclaim once lost.
In medicinal chemistry, the difference between a promising molecule and a dead end comes down to the details. Many arylboronic acids serve as linchpins for biaryl synthesis, but only certain substitution patterns confer the right balance between reactivity, selectivity, and downstream modifiability. The combination of a chloro group and ethoxy group positions 2-Chloro-4-Ethoxyphenylboronic Acid as more than just a generic cross-coupling partner. Process teams value that it enables selective coupling, opening possibilities for further elaboration or for integration into densely functionalized molecules. Feedback from on-the-ground chemists drives us to keep supply tight and quality consistent, from milligram to multi-kilogram orders. Transparent batch-to-batch data empowers users to troubleshoot scale-up issues or switch synthetic routes with minimal risk. In turn, their discoveries push us to revisit and refine our own processes, sometimes leading us to overhaul a step to improve throughput or solvent economy.
A big part of our credibility—earned over repeated project cycles—comes from candidly sharing limitations. For instance, some early-career chemists expect boronic acids to behave as wet chemistry standards. Yet these materials require real respect for storage risks, especially in humid climates or for extended storage before use. By documenting handling stories, batch anomalies, and customer advice, we help reduce surprises and costly delays. Direct, honest dialogue with users—whether in a pre-purchase consultation or technical troubleshooting—keeps the science real and useful.
Reliable supply is as important as molecular performance. Our direct control over synthesis—rather than outsourcing or working through brokers—lets us quickly communicate changes and maintain traceability for every lot. We document all supply chain inputs, keeping a close eye on raw material origins, which helps clients in the pharmaceutical sector meet increasingly strict audit and dossier requirements. Our team regularly reviews local and international compliance updates, adapting documentation and raw material sourcing as standards evolve. This isn’t just about keeping up appearances—it’s about guaranteeing safety and sustainability to clients with real checkpoints and risk assessments on the line.
Waste management receives priority in our facility planning. Boronic acid synthesis can generate organotin or nickel byproducts, and over time we refined purification steps to cut environmental loads. We adopted solvent recovery and minimized water use, both to lower costs and to address growing client interest in sustainable procurement. Lessons from large-scale operations convinced us that responsible chemistry, though sometimes slower or more expensive initially, secures relationships and reduces surprises further down the pipeline. Clients increasingly ask about solvent selection, waste output, and recyclability, so our technical staff works hand-in-hand with EHS teams to ensure answers come from well-documented plant practices—not just marketing flyers.
Our commitment to 2-Chloro-4-Ethoxyphenylboronic Acid starts in the plant and extends right to the chemist’s bench. We focus on the practicalities—long-term supply, robust documentation, open feedback loops, and constant process improvement. Our experience shows that communication with end users solves more problems than any tweak to paperwork or packaging ever will. Clients benefit from direct access to chemists and plant teams, not just sales reps, which allows for tailored solutions: altered particle sizes to improve mixing, tighter water controls for sensitive projects, or even customized batch sizes. The knowledge our team develops goes right back into early-stage synthesis choices and shipping controls.
For organizations weighing which boronic acid tos elect for novel molecule development, the fine-tuned performance and reliable supply chains make the difference. It's not just about what’s on the label—it's about realistic, pilot-tested supply, manufacturing consistency, and expert support when variables shift mid-project. We have learned these lessons through every feedback call, rejected lot, and emergency resupply. The difference people notice, batch to batch, is built right into day-to-day practices: tighter controls, a willingness to admit and fix mistakes, and respect for both the molecule and the chemists who continue to innovate with it.
Anyone can list chemical specifications. What sets sustained success apart is direct, honest experience with molecules under real-world conditions: the tweaks to a crystallization temperature that cut haze, the customer phone call that flagged an outlier, the calculated risks that proved worthwhile as R&D targets advanced. Our commitment to supplying 2-Chloro-4-Ethoxyphenylboronic Acid has always tracked back to supporting that journey—practical science for practical progress.